Julayi 2021: I-Beta-thalassemia yisimo esizuzwe njengefa esidalwa ukuguquka kwezakhi zofuzo okubandakanyeka ekukhiqizweni kwengxenye ye-hemoglobin, iphrotheni ehambisa umoya-mpilo emzimbeni wonke. Lezi zinguquko zivimbela noma zikhawulele ukwakheka kwe-hemoglobin, okuholela ekushodeni kwamaseli abomvu avuthiwe kanye ne-anemia ephikelelayo, kanye ne-iron eyeqile.
Ukuguqulwa okubangela i-beta thalassemia kuthinta cishe abantu abayizigidi ezingama-80-90 emhlabeni wonke, noma cishe amaphesenti ayi-1.5 wabantu.
Children frequently inherit the gene mutation from parents who are carriers but show no signs of the condition. The child has a 25% probability of acquiring beta-thalassemia and a 50% chance of being an asymptomatic carrier like their parents in this circumstance.
Many individuals with beta-thalassemia need regular blood transfusions for the rest of their lives (transfusion-dependent thalassemia), which can cause a variety of health problems, including iron excess, which can harm the heart, liver, and endocrine system.
Abanye kungenzeka bangadingi ukumpontshelwa njalo ukuze basinde (kuncike ekungampontshelweni igazi), kepha noma kunjalo bane-thrombosis, umfutho wegazi ophakeme wamaphaphu, ukwehluleka kwezinso, nezilonda zomlenze, phakathi kwezinye izinkinga zempilo.
I-beta thalassemia isakazeka ngokushesha okukhulu kunangaphambili
People from the Mediterranean, the Middle East, North Africa, India, and Central and Southeast Asia have been reported to have the highest prevalence of i-beta thalassemia. As a result of the rise in modern migration, instances are increasingly sprouting up in more places.
Amazwe aseningizimu yeMedithera akhulise izinsiza zokubhekana nesidingo esikhulayo seziguli ze-beta-thalassemia. Ngenkathi ochwepheshe bezempilo nosopolitiki eNyakatho naseNtshonalanga Yurophu bewubona lo mkhuba, abanayo imininingwane eqinile ngokuvela kwalesi sifo namaphethini. Kunzima ukwenza icala lokutshala imali ezinhlelweni zokuxazulula inkinga ngaphandle kwedatha, okwenza kube nzima ngeziguli ukukhomba abahlinzeki abafanele.
I-Beta-thalassemia ne-COVID-19
Ukwelashwa kwe-beta-thalassemia kudinga inani elikhulu lolwazi nezinsizakusebenza, kufaka phakathi iminikelo yegazi ephephile. Ubhadane lwe-COVID-19 lube nomthelela omkhulu ekunikezelweni kwegazi emhlabeni jikelele, okuholele ekwehleni kweminikelo yegazi emazweni amaningi e-EU kanye nezinkinga ezihlukile emazweni asafufusa nalawo ahola kancane anezinsizakusebenza ezinqunyelwe kanye nokugxila okuphezulu kweziguli ezigulayo. Ukugwema abanikeli namandla alinganiselwe ezindaweni ezinikelwayo, kanye nokuphazanyiswa kokucutshungulwa kwegazi nokunikezwa kwempahla, konke kube nomthelela ekwehleni kweminikelo yegazi.
Imibuso emisha yokwelashwa ye-beta-thalassemia
The only solution for beta-thalassemia now available is a stem cell transplant, although many individuals may not be eligible. Only around 10% of patients who are eligible for a stem cell transplant actually get one, owing to exorbitant expenses or a lack of a donor. Another long-term strategy is prevention through carrier screening and education, which has proven to be effective in several countries.
Kodwa-ke, intuthuko yakamuva emkhakheni wezokwelapha inikeze ukukhetha okudingeka kakhulu ekubhekaneni ne-anemia ebangelwa yi-beta-thalassemia nokuvumela iziguli ukuthi zinganciki kakhulu ekumpontshelweni kwamangqamuzana egazi abomvu.
